Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
426,20 € ↑6,40 (1,52%)
2026-06-04
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership57,177 shares
Latest Disclosed Value $ 29,930,444
Bnp Paribas Arbitrage, Sa reports 22.43% decrease in ownership of YDO1 / Madrigal Pharmaceuticals, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 57,177 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1) valued at $25,746,803 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 73,707 shares of Madrigal Pharmaceuticals, Inc.. This represents a change in shares of -22.43% during the quarter. The current value of the position is $24,368,837 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Madrigal Pharmaceuticals Equity 558868105 57,177 -16,530 -22.43 29,930 -30.27 0.0015
2026-02-10 2025-12-31 13F Madrigal Pharmaceuticals Equity 558868105 73,707 2,950 4.17 42,923 32.26 0.0194
2025-11-13 2025-09-30 13F Madrigal Pharmaceuticals Equity 558868105 70,757 1,720 2.49 32,453 55.33 0.0173
2025-08-14 2025-06-30 13F Madrigal Pharmaceuticals Equity 558868105 69,037 65,561 1,886.10 20,893 1,715.20 0.0120
2025-05-14 2025-03-31 13F Madrigal Pharmaceuticals Equity 558868105 3,476 -3,445 -49.78 1,151 -46.09 0.0007
2025-02-14 2024-12-31 13F Madrigal Pharmaceuticals Equity 558868105 6,921 -2,846 -29.14 2,136 3.04 0.0012
2024-11-13 2024-09-30 13F Madrigal Pharmaceuticals Equity 558868105 9,767 4,811 97.07 2,073 49.28 0.0014
2024-08-13 2024-06-30 13F Madrigal Pharmaceuticals Equity 558868105 4,956 -6,418 -56.43 1,388 -54.30 0.0011
2024-05-01 2024-03-31 13F Madrigal Pharmaceuticals Equity 558868105 11,374 -11,395 -50.05 3,037 -42.35 0.0027
2024-02-14 2023-12-31 13F/A-2 Madrigal Pharmaceuticals Equity 558868105 22,769 6,148 36.99 5,268 117.06 0.0060
2024-02-07 2023-12-31 13F/A-1 Madrigal Pharmaceuticals Equity 558868105 22,769 6,148 5,268 0.0007
2024-02-07 2023-12-31 13F Madrigal Pharmaceuticals Equity 558868105 22,769 5,268
2023-11-14 2023-09-30 13F Madrigal Pharmaceuticals Equity 558868105 16,621 6,729 68.02 2,427 6.21 0.0031
2023-08-09 2023-06-30 13F Madrigal Pharmaceuticals Equity 558868105 9,892 -3,477 -26.01 2,285 -29.43 0.0029
2023-05-12 2023-03-31 13F MADRIGAL PHARMACEUTICALS EQUITY 558868105 13,369 -33,435 -71.44 3,239 -76.16 0.0045
2023-02-14 2022-12-31 13F Madrigal Pharmaceuticals Equity 558868105 46,804 25,200 116.65 13,585 867.52 0.0209
2022-11-16 2022-09-30 13F/A-1 Madrigal Pharmaceuticals Equity 558868105 21,604 18,848 683.89 1,404 612.69 0.0022
2022-11-15 2022-09-30 13F Madrigal Pharmaceuticals Equity 558868105 21,604 18,848 1,404 0.0003
2022-08-12 2022-06-30 13F Madrigal Pharmaceuticals Equity 558868105 2,756 1,764 177.82 197 103.09 0.0003
2022-05-18 2022-03-31 13F/A-1 Madrigal Pharmaceuticals Equity 558868105 992 -1,491 -60.05 97 -53.81 0.0001
2022-02-09 2021-12-31 13F MADRIGAL PHARMACEUTICALS EQUITY 558868105 2,483 422 20.48 210 28.05 0.0003
2021-11-16 2021-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS EQUITY 558868105 2,061 1,634 382.67 164 300.00 0.0002
2021-11-12 2021-09-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 2,054 1,627 244 0.0000
2021-08-10 2021-06-30 13F MADRIGAL PHARMACEUTICALS EQUITY 558868105 427 -635 -59.79 42 -66.94 0.0001
2021-05-07 2021-03-31 13F MADRIGAL PHARMACEUTICALS EQUITY 558868105 1,062 108 11.32 124 16.98 0.0002
2021-02-10 2020-12-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 954 -1,100 -53.55 106 -56.38 0.0002
2020-10-30 2020-09-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 2,054 441 27.34 244 33.52 0.0003
2020-08-06 2020-06-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 1,613 -4,122 -71.87 183 -52.36 0.0003
2020-05-13 2020-03-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 5,735 4,615 412.05 383 274.51 0.0008
2020-02-12 2019-12-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 1,120 -225 -16.73 102 -11.30 0.0002
2019-11-07 2019-09-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 1,345 370 37.95 116 12.75 0.0002
2019-07-30 2019-06-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 975 -620 -38.87 102 -48.74 0.0002
2019-04-25 2019-03-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 1,595 1,508 1,733.33 200 2,111.11 0.0004
2019-02-12 2018-12-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 87 -195 -69.15 10 -85.00 0.0000
2018-11-07 2018-09-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 282 92 48.42 60 13.21 0.0001
2018-07-25 2018-06-30 13F SYNTA PHARMACEUTICALS EQUITY 558868105 190 -807 -80.94 53 -54.31 0.0001
2018-05-11 2018-03-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 997 141 16.47 116 48.72 0.0002
2018-03-05 2017-12-31 13F/A-1 SYNTA PHARMACEUTICALS EQUITY 558868105 856 461 116.71 79 358.82 0.0001
2018-02-01 2017-12-31 13F SYNTA PHARMACEUTICALS EQUITY 558868105 856 461 79
2017-11-03 2017-09-30 13F MADRIGAL PHARMACEUTICALS STOCK 558868105 395 -29 -6.84 18 183.33 0.0000
2017-08-03 2017-06-30 13F MADRIGAL PHARMACEUTICALS STOCK 558868105 424 424 7 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.